Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-06-07
1993-02-23
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A01N 3718
Patent
active
051890143
ABSTRACT:
A method of immunotherapy for treating diseases and disorders which involve cellular Fc receptor mediated immune responses in humans and animals is disclosed. Abnormal or undesirable cellular Fc receptor mediated immune reactions are beneficially altered by locally or systemically administering an exogenous Fc receptor polypeptide, in particular a multivalent protein having in its molecule several Fc receptor sites, such as staphylococcus protein A, or monovalent Fc receptor possessing only a single Fc receptor site.
REFERENCES:
patent: 4479934 (1984-10-01), Sedlacek et al.
Agah et al., Cancer Research, vol. 48, Apr. 15, 1988, pp. 2245-2248.
Ainsworth et al., Cancer, vol. 61, Apr. 15, 1988, pp. 1495-1500.
Axelrod et al., Cancer, vol. 61, Jun. 1, 1988, pp. 2219-2230.
Bender et al., J. of Infectious Diseases, vol. 152, Aug. 1985, pp. 405-412.
Berkow, The Merck Manual of Diagnosis & Therapy, 1977, pp. 183-255.
Berkow, The Merck Manual of Diagnosis & Therapy, 1982, pp. 288-297, 328-347.
Boyle et al., Bio/Technology, vol. 5, Jul. 1987, pp. 697-703.
Edelman et al., The FASEB Journal, vol. 3, Jan. 1989, pp. 22-30.
Engelman et al., Cancer Detection and Prevention, vol. 10, 1987, pp. 435-444.
Engelman et al., AJP, Mar. 1985, pp. 367-378.
Fauci, Science, vol. 239, Feb. 1988, pp. 617-622.
Fauci et al., Int. Archs Allergy Appl. Immun., vol. 77, (1985), pp. 81-88.
Frank et al., The New England J. of Medicine, vol. 300, Mar. 8, 1979, pp. 518-523.
Fraser et al., The Merck Veterinary Manual, 1986, pp. 409-424.
Fraser et al., Structure and Function of Fc Receptors, 1983, pp. iii-xv and 1-13.
Homsy et al., Science, vol. 244, pp. 1357-1360, 1989.
Kerbel et al., Cell, vol. 3, Oct. 1974, pp. 105-112.
Kinet et al., European J. of Clinical Investigation, vol. 16, 1986, pp. 50-55.
Lange et al., Aids, 1987, vol. 1, pp. 155-159.
Liu et al., Proc. Natl. Acad. Sci. USA, vol. 81, Oct. 1984, pp. 6471-6475.
MacKinnon et al., Arthritis and Rheumatism, vol. 30, May 1987, pp. 498-506.
Jennette et al., Federation Proceedings, vol. 141, Mar. 1, 1982, p. 325.
Messerschmidt et al., J. of Clinical Oncology, vol. 6, Feb. 1988, pp. 203-212.
Mullins et al., Nature, vol. 319, Jan. 1986, pp. 333-336.
Nauts, Develop. Biol. Standard, vol. 38, 1978, pp. 487-494.
Old, Scientific American, vol. 258, May 1988, pp. 59-75.
Paranjpe et al., J. of the National Cancer Institute, vol. 48, Feb. 1972, pp. 563-566.
Ray et al., Cancer Immunology Immunotherapy, vol. 18, 1984, pp. 29-34.
Ray et al., Cancer, vol. 45, May 15, 1980, pp. 2633-2638.
Ray et al., Cancer Research, vol. 42, Dec. 1982, pp. 4970-4974.
Rhodes, Nature, vol. 265, Jan. 20, 1977, pp. 253-255.
Rhodes et al., J. of National Cancer Inst., vol. 66, 1981, p. 423.
Roses et al., Manual of Clinical Immunology, 2nd. Ed., 1980, pp. 178-211.
Sarin et al., Science, vol. 232, May 30, 1986, pp. 1135-1137.
Sinclair, Immunology Today, vol. 8, 1987, pp. 76-79.
Sinclair et al., Clinical Immunology and Immunopathology, vol. 52 1989, pp. 133-146.
Sjodahl, Eur. J. Biochem., vol. 78, 1977, pp. 471-490.
Stole et al., Int. J. Cancer, vol. 14, 1974, pp. 83-92.
Sulica et al., Sand. J. Immunol., vol. 5, 1976, pp. 1191-1197.
Takeda et al., Science, vol. 242, Oct. 28, 1988, pp. 580-583.
Tavares et al., Cancer Research, vol. 47, 1987, pp. 3190-3194.
Terman, The New England J. of Medicine, vol. 305, 1981, pp. 1195-1200.
Tizard, An Introduction to Veterinary Immunology, 1977, pp. 81, 98, 108.
Field Milton M.
Hook Gregory
Waddell Frederick E.
LandOfFree
Method of treating cellular Fc receptor mediated hypersensitivit does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating cellular Fc receptor mediated hypersensitivit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating cellular Fc receptor mediated hypersensitivit will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2204798